New and Emerging Antibiotics for Complicated Intra-Abdominal Infections

American Journal of Therapeutics
Cheryl R DurandKristine C Willett

Abstract

The purpose of this review is to evaluate the efficacy and safety of ceftazidime/avibactam and ceftolozane/tazobactam in patients with complicated intra-abdominal infections (cIAI), and review eravacycline and other agents in the pipeline for management of cIAI. The increasing incidence of multidrug resistant strains of bacteria has led to the need for additional antibiotics with activity against these organisms. There are 2 newly approved antibiotics, ceftazidime/avibactam and ceftolazane/tazobactam for treatment of cIAI. Both agents have been shown to exert activity against resistant bacteria, including extended-spectrum beta-lactamase-producing organisms. Several other antibiotics are currently under investigation for this indication. Included in the pipeline of agents is a new tetracycline, an aminoglycoside, 2 new fluroquinolones, and 2 new beta-lactamase inhibitor combinations with carbapenems. Although the mechanisms for these new agents are not novel, promising data have shown their ability to overcome class resistance. The passing of the Generating Antibiotic Incentives Now Act has led to an increasing number of fast tracked antibiotic approvals. In addition to recent approval of ceftazidime/avibactam and ceftolazane/t...Continue Reading

References

Dec 26, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Joseph S SolomkinJohn G Bartlett
Sep 29, 2011·The Journal of Antimicrobial Chemotherapy·Evgeny A IdelevichKarsten Becker
Aug 10, 2012·The Journal of Antimicrobial Chemotherapy·Joan M RemyJoseph A Devito
Apr 2, 2013·Diagnostic Microbiology and Infectious Disease·Tim BabinchakSamuel Bouchillon
May 1, 2013·Antimicrobial Agents and Chemotherapy·Brian VanScoyPaul G Ambrose
Aug 28, 2013·Antimicrobial Agents and Chemotherapy·J A SutcliffeT H Grossman
Jan 18, 2014·Bioorganic & Medicinal Chemistry Letters·Timothy A BlizzardMilton L Hammond
Jun 3, 2014·World Journal of Emergency Surgery : WJES·Massimo SartelliRita Barnabé
Feb 12, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Joseph SolomkinChristian Eckmann

❮ Previous
Next ❯

Citations

Jul 8, 2017·British Journal of Pharmacology·Wei ZhengAnton Simeonov
Apr 8, 2021·Expert Opinion on Pharmacotherapy·Joseph P LynchGeorge G Zhanel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.